722 related articles for article (PubMed ID: 32113575)
1. Systemic sclerosis-associated interstitial lung disease.
Perelas A; Silver RM; Arrossi AV; Highland KB
Lancet Respir Med; 2020 Mar; 8(3):304-320. PubMed ID: 32113575
[TBL] [Abstract][Full Text] [Related]
2. [New developments in systemic sclerosis-associated interstitial lung disease].
Humair G; Daccord C; Beigelman-Aubry C; Lazor R
Rev Med Suisse; 2020 Nov; 16(715):2218-2223. PubMed ID: 33206479
[TBL] [Abstract][Full Text] [Related]
3. Systemic Sclerosis and Pulmonary Disease.
Ngo K
Adv Exp Med Biol; 2021; 1303():173-182. PubMed ID: 33788193
[TBL] [Abstract][Full Text] [Related]
4. Interstitial lung disease in systemic sclerosis.
Renzoni EA
Monaldi Arch Chest Dis; 2007 Dec; 67(4):217-28. PubMed ID: 18309700
[TBL] [Abstract][Full Text] [Related]
5. Interstitial lung disease in systemic sclerosis.
Bussone G; Mouthon L
Autoimmun Rev; 2011 Mar; 10(5):248-55. PubMed ID: 20863911
[TBL] [Abstract][Full Text] [Related]
6. The Treatment of Lung Involvement in Systemic Sclerosis.
Ruaro B; Confalonieri M; Matucci-Cerinic M; Salton F; Confalonieri P; Santagiuliana M; Citton GM; Baratella E; Bruni C
Pharmaceuticals (Basel); 2021 Feb; 14(2):. PubMed ID: 33668530
[TBL] [Abstract][Full Text] [Related]
7. [Diffuse interstitial lung disorders in systemic diseases].
Kips JC
Verh K Acad Geneeskd Belg; 2003; 65(6):350-65. PubMed ID: 14964036
[TBL] [Abstract][Full Text] [Related]
8. Scleroderma lung disease.
Le Pavec J; Launay D; Mathai SC; Hassoun PM; Humbert M
Clin Rev Allergy Immunol; 2011 Apr; 40(2):104-16. PubMed ID: 20063208
[TBL] [Abstract][Full Text] [Related]
9. Chronic dyspnea with Raynaud's phenomenon and elevated ANA: A diagnosis of systemic sclerosis sine scleroderma.
Chong WH; Saha BK; Beegle S
Am J Med Sci; 2023 Feb; 365(2):198-204. PubMed ID: 35276077
[TBL] [Abstract][Full Text] [Related]
10. Interstitial lung disease in systemic sclerosis.
Cheema GS; Quismorio FP
Curr Opin Pulm Med; 2001 Sep; 7(5):283-90. PubMed ID: 11584177
[TBL] [Abstract][Full Text] [Related]
11. [Importance of mycophenolate mofetil for treatment of interstitial lung disease in systemic sclerosis].
Schneider U; Siegert E; Gläser S; Krüger K; ; Krause A
Z Rheumatol; 2021 Nov; 80(9):868-878. PubMed ID: 34545432
[TBL] [Abstract][Full Text] [Related]
12. [Interstitial lung disease in systemic sclerosis].
Mouthon L; Berezné A; Brauner M; Kambouchner M; Guillevin L; Valeyre D
Presse Med; 2006 Dec; 35(12 Pt 2):1943-51. PubMed ID: 17159721
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in the diagnosis and treatment of interstitial lung disease in systemic sclerosis (scleroderma): a review.
Tan A; Denton CP; Mikhailidis DP; Seifalian AM
Clin Exp Rheumatol; 2011; 29(2 Suppl 65):S66-74. PubMed ID: 21586221
[TBL] [Abstract][Full Text] [Related]
14. Relevance of immunomodulatory therapy for interstitial lung disease in systemic sclerosis.
Aringer M; Riemekasten G
Best Pract Res Clin Rheumatol; 2021 Sep; 35(3):101672. PubMed ID: 33745826
[TBL] [Abstract][Full Text] [Related]
15. Interstitial lung disease in scleroderma.
Schoenfeld SR; Castelino FV
Rheum Dis Clin North Am; 2015 May; 41(2):237-48. PubMed ID: 25836640
[TBL] [Abstract][Full Text] [Related]
16. Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial.
Tashkin DP; Roth MD; Clements PJ; Furst DE; Khanna D; Kleerup EC; Goldin J; Arriola E; Volkmann ER; Kafaja S; Silver R; Steen V; Strange C; Wise R; Wigley F; Mayes M; Riley DJ; Hussain S; Assassi S; Hsu VM; Patel B; Phillips K; Martinez F; Golden J; Connolly MK; Varga J; Dematte J; Hinchcliff ME; Fischer A; Swigris J; Meehan R; Theodore A; Simms R; Volkov S; Schraufnagel DE; Scholand MB; Frech T; Molitor JA; Highland K; Read CA; Fritzler MJ; Kim GHJ; Tseng CH; Elashoff RM;
Lancet Respir Med; 2016 Sep; 4(9):708-719. PubMed ID: 27469583
[TBL] [Abstract][Full Text] [Related]
17. Where are we going in the management of interstitial lung disease in patients with systemic sclerosis?
Iudici M; Moroncini G; Cipriani P; Giacomelli R; Gabrielli A; Valentini G
Autoimmun Rev; 2015 Jul; 14(7):575-8. PubMed ID: 25709096
[TBL] [Abstract][Full Text] [Related]
18. The Impact of Progressive Pulmonary Fibrosis in Systemic Sclerosis-Associated Interstitial Lung Disease.
Martín-López M; Carreira PE
J Clin Med; 2023 Oct; 12(20):. PubMed ID: 37892818
[TBL] [Abstract][Full Text] [Related]
19. Management of systemic sclerosis-associated interstitial lung disease.
Roofeh D; Jaafar S; Vummidi D; Khanna D
Curr Opin Rheumatol; 2019 May; 31(3):241-249. PubMed ID: 30870216
[TBL] [Abstract][Full Text] [Related]
20. [Interstitial pneumonia preceding systemic sclerosis].
Imokawa S; Sato A; Sato J; Tsukamoto K; Todate A; Toyoshima M; Suda T; Hayakawa H; Chida K; Iwata M
Nihon Kokyuki Gakkai Zasshi; 1998 Nov; 36(11):969-72. PubMed ID: 9916482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
